These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 2153298

  • 21. Dexamethasone increases 1,25-dihydroxyvitamin D3 receptor levels and augments bioresponses in rat osteoblast-like cells.
    Chen TL, Hauschka PV, Feldman D.
    Endocrinology; 1986 Mar; 118(3):1119-26. PubMed ID: 3004896
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. The 1,25-dihydroxy-vitamin D3 receptor is phosphorylated in response to 1,25-dihydroxy-vitamin D3 and 22-oxacalcitriol in rat osteoblasts, and by casein kinase II, in vitro.
    Jurutka PW, Terpening CM, Haussler MR.
    Biochemistry; 1993 Aug 17; 32(32):8184-92. PubMed ID: 8394128
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Human and murine osteocalcin gene expression: conserved tissue restricted expression and divergent responses to 1,25-dihydroxyvitamin D3 in vivo.
    Sims NA, White CP, Sunn KL, Thomas GP, Drummond ML, Morrison NA, Eisman JA, Gardiner EM.
    Mol Endocrinol; 1997 Oct 17; 11(11):1695-708. PubMed ID: 9328351
    [Abstract] [Full Text] [Related]

  • 26. Nonhypercalcemic 1,25-(OH)2D3 analogs potently induce the human osteocalcin gene promoter stably transfected into rat osteosarcoma cells (ROSCO-2).
    Morrison NA, Eisman JA.
    J Bone Miner Res; 1991 Aug 17; 6(8):893-9. PubMed ID: 1785378
    [Abstract] [Full Text] [Related]

  • 27. Influence of 1,25-dihydroxyvitamin D3 on cultured osteogenic sarcoma cells: correlation with the 1,25-dihydroxyvitamin D3 receptor.
    Dokoh S, Donaldson CA, Haussler MR.
    Cancer Res; 1984 May 17; 44(5):2103-9. PubMed ID: 6324995
    [Abstract] [Full Text] [Related]

  • 28. Characterization of the rat osteocalcin gene: stimulation of promoter activity by 1,25-dihydroxyvitamin D3.
    Yoon KG, Rutledge SJ, Buenaga RF, Rodan GA.
    Biochemistry; 1988 Nov 15; 27(23):8521-6. PubMed ID: 3265336
    [Abstract] [Full Text] [Related]

  • 29. Identification of a vitamin D responsive element in the promoter of the rat cytochrome P450(24) gene.
    Hahn CN, Kerry DM, Omdahl JL, May BK.
    Nucleic Acids Res; 1994 Jun 25; 22(12):2410-6. PubMed ID: 8036172
    [Abstract] [Full Text] [Related]

  • 30. Regulation of human placental lactogen expression by 1,25-dihydroxyvitamin D3.
    Stephanou A, Ross R, Handwerger S.
    Endocrinology; 1994 Dec 25; 135(6):2651-6. PubMed ID: 7988455
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3.
    Zella LA, Kim S, Shevde NK, Pike JW.
    Mol Endocrinol; 2006 Jun 25; 20(6):1231-47. PubMed ID: 16497728
    [Abstract] [Full Text] [Related]

  • 37. Association between the expression of the c-myc oncogene mRNA and the expression of the receptor protein for 1,25-dihydroxyvitamin D3.
    Manolagas SC, Provvedini DM, Murray EJ, Murray SS, Tsonis PA, Spandidos DA.
    Proc Natl Acad Sci U S A; 1987 Feb 25; 84(3):856-60. PubMed ID: 3027709
    [Abstract] [Full Text] [Related]

  • 38. Evidence for coordinated regulation of osteoblast function by 1,25-dihydroxyvitamin D3 and parathyroid hormone.
    van Leeuwen JP, Birkenhäger JC, van den Bemd GC, Pols HA.
    Biochim Biophys Acta; 1996 Jun 05; 1312(1):54-62. PubMed ID: 8679716
    [Abstract] [Full Text] [Related]

  • 39. Overproduction of rat 1,25-dihydroxyvitamin D3 receptor in insect cells using the baculovirus expression system.
    Ross TK, Prahl JM, DeLuca HF.
    Proc Natl Acad Sci U S A; 1991 Aug 01; 88(15):6555-9. PubMed ID: 1650474
    [Abstract] [Full Text] [Related]

  • 40. The human transient receptor potential vanilloid type 6 distal promoter contains multiple vitamin D receptor binding sites that mediate activation by 1,25-dihydroxyvitamin D3 in intestinal cells.
    Meyer MB, Watanuki M, Kim S, Shevde NK, Pike JW.
    Mol Endocrinol; 2006 Jun 01; 20(6):1447-61. PubMed ID: 16574738
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.